JSPRW icon

Japer Therapeutics Warrants
JSPRW

7 hedge funds and large institutions have $372K invested in Japer Therapeutics Warrants in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
7
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$911
2
+$34

Top Sellers

1
-$1.03K
2
-$569
3
-$4
4
CS
Clear Street
New York
-$4
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
1
Boothbay Fund Management
New York
$313K
Toronto Dominion Bank
2
Toronto Dominion Bank
Ontario, Canada
$47.8K
TCM
3
Tenor Capital Management
New York
$5.47K
Walleye Capital
4
Walleye Capital
New York
$4.38K
Susquehanna International Group
5
Susquehanna International Group
Pennsylvania
$618
JP Morgan Chase
6
JP Morgan Chase
New York
$59
WAM
7
Wolverine Asset Management
Illinois
$23
IA
8
IFP Advisors
Florida
$1
TC
9
T3 Companies
New York
–
Bank of America
10
Bank of America
North Carolina
–
CS
11
Clear Street
New York
–